Upcoming Events

18th International Myeloma Workshop

18th International Myeloma Workshop

September 8 - 11, 2021 - Vienna, Austria

The International Myeloma Workshop is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:

  • Scientific Programs
  • Oral Presentations (on Basic Biology, Preclinical Trials and Clinical Studies)
  • Consensus Panels
  • Poster Presentations

18th IMW Preliminary Program

Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

About Our Publications

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

See All Publications

Translational Research Grant

The International Myeloma Society and Paula and Rodger Riney Foundation are proud to announce a new initiative “IMS Translational Research Award”. We anticipate funding grants focused on translational research in the field of plasma cell dyscrasias. 

Waldenstrom Award

The Waldenström Award (WA) is given by the IMS at each International Myeloma Workshop (IMW) starting in 1989. This award is given to outstanding researchers in recognition to their contributions to the myeloma field.  The award is named for Professor Jan Waldenström, who was a pioneer in treating blood cancers.

Career Development Award

The International Myeloma Society is proud to announce a new initiative “IMS Career Development Award”. The IMS anticipates funding grants for young investigators focused on research in the field of plasma cell dyscrasias.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events